Literature DB >> 22323654

Neuroprotective role of the TREK-1 channel in decompression sickness.

Nicolas Vallee1, Cédric Meckler, Jean-Jacques Risso, Jean-Eric Blatteau.   

Abstract

Nitrogen supersaturation and bubble formation can occur in the vascular system after diving, leading to death and nervous disorders from decompression sickness (DCS). Bubbles alter the vascular endothelium, activate platelets, and lead to focal ischemia with neurological damage mediated by the mechanosensitive TREK-1 neuronal potassium ion channel that sets pre- and postsynaptic resting membrane potentials. We report a neuroprotective effect associated with TREK-1. C57Bl6 mice were subjected to decompression from a simulated 90 msw dive. Of 143 mice that were wild type (WT) for TREK-1, 51.7% showed no DCS, 27.3% failed a grip test, and 21.0% died. Of 88 TREK-1 knockouts (KO), 26.1% showed no DCS, 42.0% failed a grip test, and 31.8% died. Mice that did not express TREK-1 had lower DCS resistance and were more likely to develop neurological symptoms. We conclude that the TREK-1 potassium channel was neuroprotective for DCS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22323654     DOI: 10.1152/japplphysiol.01100.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

Review 1.  Temperature sensitivity of two-pore (K2P) potassium channels.

Authors:  Eve R Schneider; Evan O Anderson; Elena O Gracheva; Sviatoslav N Bagriantsev
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

2.  Electrophysiology and pharmacology of tandem domain potassium channel TREK-1 related BDNF synthesis in rat astrocytes.

Authors:  Li Lu; Weiping Wang; Ying Peng; Jiang Li; Ling Wang; Xiaoliang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-09       Impact factor: 3.000

3.  Protective effects of fluoxetine on decompression sickness in mice.

Authors:  Jean-Eric Blatteau; Sandrine Barre; Aurelie Pascual; Olivier Castagna; Jacques H Abraini; Jean-Jacques Risso; Nicolas Vallee
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

4.  Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the "spadin" Antidepressant.

Authors:  Nicolas Vallée; Kate Lambrechts; Sébastien De Maistre; Perrine Royal; Jean Mazella; Marc Borsotto; Catherine Heurteaux; Jacques Abraini; Jean-Jacques Risso; Jean-Eric Blatteau
Journal:  Front Physiol       Date:  2016-02-16       Impact factor: 4.566

5.  Xenon Blocks Neuronal Injury Associated with Decompression.

Authors:  Jean-Eric Blatteau; Hélène N David; Nicolas Vallée; Cedric Meckler; Sebastien Demaistre; Kate Lambrechts; Jean-Jacques Risso; Jacques H Abraini
Journal:  Sci Rep       Date:  2015-10-15       Impact factor: 4.379

6.  Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness.

Authors:  Caroline Cosnard; Sébastien De Maistre; Jacques H Abraini; Laurent Chazalviel; Jean-Eric Blatteau; Jean-Jacques Risso; Nicolas Vallée
Journal:  Front Physiol       Date:  2017-09-05       Impact factor: 4.566

7.  Demonstration by Infra-Red Imaging of a Temperature Control Defect in a Decompression Sickness Model Testing Minocycline.

Authors:  Anne-Virginie Desruelle; Pierre Louge; Simone Richard; Jean-Eric Blatteau; Sandrine Gaillard; Sébastien De Maistre; Hélène David; Jean-Jacques Risso; Nicolas Vallée
Journal:  Front Physiol       Date:  2019-07-24       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.